Spry Therapeutics, a health and wellness technology company, announced today that it will donate 10,000 of its filtered healthcare pillows, the Spry Medical Pillow, to hospitals across the United States to help thwart the spread of COVID-19 and other harmful pathogens, such as MRSA, C. diff, E. coli, and Candida auris. Hospitals who are interested in the filtered Spry pillow can inquire by contacting Spry at email@example.com. Additionally, Spry has announced that it will be offering the Spry Medical Pillow — previously only available to hospitals and medical facilities — to consumers at a greatly reduced cost.
The emergence and spread of COVID-19 around the U.S. and the globe has spurred calls for new methods and procedures that help minimize the spread of viruses, bacteria, and other potentially deadly pathogens. One of the biggest areas of concern for the spread of pathogens is soft surfaces (i.e., bedding, pillows, and seat cushions), as these are typically long-term reservoirs for contamination. And, given today’s struggle against COVID-19, this is true not only for healthcare, but in industries such as hospitality as well, which sees, on average, 4.8 million guests stay in hotels and lodging accommodations each night.
Most of the pillows available in the market today — to hospitals, hotels, and consumers — are susceptible to contamination due to their stitched seams. The current method of stitching pillows enables countless pathogens to enter and accumulate within the pillow’s interior, potentially contaminating pillow users — and those in close proximity — each time they lay down.
The Spry Medical Pillow, along with others in Spry’s suite, utilizes the world’s first and only soft-surface filter technology, Pneumapure®. The company’s patented filter technology blocks even the smallest “superbugs” — as small as .02 microns — from entering or exiting any soft surface to which it’s applied, helping prevent the transmission of deadly diseases among patients, caregivers, and consumers. This technology has been independently tested and proven effective in blocking viruses (including coronavirus) and other dangerous pathogens from entering the core of the pillow.
Additionally, the initial results of an ongoing study conducted at North Shore University Hospital (part of Northwell Health System) have shown that at the end of a six-month period of active use involving all patient units and the Emergency Room, no bacteria was detected on the interiors of any Spry Medical Pillows tested.
Pneumapure also potentially reduces costs associated with healthcare-acquired infections (HAIs), including the environmental impact and disposal costs related to traditionally-used products.
“Over the last several weeks, the COVID-19 pandemic has brought to the forefront many questions and concerns around health and the spread of germs — from washing our hands, to the significance of not touching our faces, to how we interact with others. Although these are important, it is imperative that we also consider the potential harm caused by the contaminated interiors of pillows and mattresses,” said Bill Purdy, Co-Founder and CEO of Spry Therapeutics. “What many people don’t realize is that soft surfaces, like pillows, harbor many harmful germs. It is our mission to help not only the healthcare industry, but consumers, understand and address the dangers of soft surfaces and offer them effective and affordable alternatives.”
To receive more information regarding Spry’s efforts to help combat COVID-19, or to learn how your facility can implement Pneumapure filter technology, contact firstname.lastname@example.org or call (866) 293-8691.
Consumers can purchase the Spry Medical Pillow online by visiting https://bit.ly/2wghnqI.
To learn more about Spry Therapeutics and its Pneumapure filter technology, visit sprytx.com.